Trademark Details For BIOPS (Serial Number 86760692)

  •  Home
  •  Print
BIOPS
0
0
0
0
Serial Number  United States - USPTO 86760692
Registration Number 5152951
Mark
BIOPS
Filing Date Sep-18-2015
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
TTAB
0
Action Tags
  



  • Description Of Mark:
  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Mar-09-2012

First Use in Commerce: Aug-08-2012





Correspondences

NameL. S. VanLandingham III
Address91 Lakemaster Lane Lake Havasu City, AZ 86403

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Sep-22-2015NEW APPLICATION ENTERED   NWAPI
Sep-22-2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jan-06-2016ASSIGNED TO EXAMINER   DOCKD
Jan-09-2016
NON-FINAL ACTION WRITTEN
  
CNRTR
Jan-09-2016NON-FINAL ACTION E-MAILED   GNRTF
Jan-09-2016
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Jun-30-2016TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Jul-07-2016ASSIGNED TO LIE   ALIEA
Jul-12-2016CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Jul-12-2016TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Aug-05-2016
NON-FINAL ACTION WRITTEN
  
CNRTR
Aug-05-2016
NON-FINAL ACTION E-MAILED
  
GNRTO
Aug-05-2016
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Dec-10-2016TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Dec-10-2016CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Dec-12-2016TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Jan-03-2017APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER   CNTAO
Jan-23-2017LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
Feb-28-2017REGISTERED-SUPPLEMENTAL REGISTER   R.SRA
Feb-28-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Feb-15-2023TEAS SECTION 8 RECEIVED   ES8RI
Jul-27-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jul-27-2023REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
Jul-27-2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E